UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer

被引：0
|
作者：
C Alliot
机构：
[1] General Hospital of Annemasse,Hematology/Oncology Division
[2] BP 525,undefined
来源：
British Journal of Cancer | 2004年 / 91卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：599 / 600
页数：1
相关论文
共 50 条
  • [21] UFT/leucovorin combined with mitomycin-C in metastatic colorectal Ca
    Jakobsen, A
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 32 - 34
  • [22] Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer
    Méndez, M
    Alfonso, PG
    Pujol, E
    González, E
    Castañon, C
    Cerezuela, P
    López-Mateos, Y
    Cruz, JJ
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 243 - 251
  • [23] Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer
    M. Méndez
    P. G. Alfonso
    E. Pujol
    E. González
    C. Castañon
    P. Cerezuela
    Y. López-Mateos
    J. J. Cruz
    Investigational New Drugs, 2005, 23 : 243 - 251
  • [24] UFT/leucovorin vs 5-FU/leucovorin in colon cancer
    Smith, RE
    Lembersky, BC
    Wieand, HS
    Colangelo, L
    Mamounas, EP
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 24 - 27
  • [25] UFT(R) modulated with leucovorin in advanced colorectal cancer: Oncopaz experience
    Baron, MG
    Feliu, J
    Giron, CG
    Espinosa, J
    Martinez, B
    Blanco, E
    Crespo, MC
    Ordonez, A
    Espinosa, E
    deCastro, J
    Juarez, F
    Colmenarejo, A
    ONCOLOGY, 1997, 54 : 24 - 29
  • [26] Phase II study of UFT(R) plus leucovorin in colorectal cancer
    Pazdur, R
    ONCOLOGY, 1997, 54 : 19 - 23
  • [27] A phase II study of UFT and leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer
    Gyldenkerne, N
    Glimelius, B
    Frödin, JE
    Kjaer, M
    Pfeiffer, P
    Hansen, F
    Keldsen, N
    Sandberg, E
    Jakobsen, A
    ACTA ONCOLOGICA, 2004, 43 (03) : 276 - 279
  • [28] Oral uracil/tegafur (UFT) plus leucovorin (LV) in patients with metastatic colorectal cancer (CRC)
    Goker, E
    Aykan, NF
    Serdengecti, S
    Gunel, N
    Alakavuklar, M
    Icli, F
    Yucel, I
    Uskent, N
    Arpaci, F
    Firat, D
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
  • [29] Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (LV) (SCOUT) in patients with advanced colorectal cancer (ACRC): A phase I/II study
    Sheikh, H.
    Valle, J. W.
    Palmer, K.
    Wilson, G.
    Sjursen, A.
    Craven, O.
    Swindell, R.
    Saunders, M. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] A phase I study of oral uracil/tegafur (UFT) plus leucovorin (LV) combined with oxaliplatin in patients with metastatic colorectal cancer (CRC).
    Douillard, JY
    Dissoubray, C
    Seitz, JF
    CLINICAL CANCER RESEARCH, 2000, 6 : 4574S - 4574S
12345